Latest Insider Transactions at Elevance Health, Inc. (ELV)
This section provides a real-time view of insider transactions for Elevance Health, Inc. (ELV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Elevance Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Elevance Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2020
|
Gail Boudreaux President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,764
-21.6%
|
$4,621,132
$313.9 P/Share
|
|
Nov 16
2020
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Open market or private sale
|
Direct |
5,834
-2.32%
|
$1,942,722
$333.9 P/Share
|
|
Nov 16
2020
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
BUY
Exercise of conversion of derivative security
|
Direct |
1,708
+2.2%
|
$210,084
$123.85 P/Share
|
|
Nov 09
2020
|
Ronald W Penczek CAO & Controller |
SELL
Open market or private sale
|
Direct |
1,199
-27.08%
|
$395,670
$330.75 P/Share
|
|
Nov 03
2020
|
Thomas C Zielinski EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
9,175
-10.2%
|
$2,679,100
$292.35 P/Share
|
|
Nov 03
2020
|
Thomas C Zielinski EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,893
+8.73%
|
$439,176
$232.04 P/Share
|
|
Oct 15
2020
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Open market or private sale
|
Direct |
5,834
-2.42%
|
$1,703,528
$292.05 P/Share
|
|
Oct 15
2020
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
BUY
Exercise of conversion of derivative security
|
Direct |
4,667
+9.87%
|
$466,700
$100.77 P/Share
|
|
Oct 09
2020
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Open market or private sale
|
Direct |
1,167
-2.98%
|
$344,265
$295.0 P/Share
|
|
Oct 02
2020
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Open market or private sale
|
Direct |
4,667
-10.66%
|
$1,306,760
$280.0 P/Share
|
|
Oct 02
2020
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
BUY
Exercise of conversion of derivative security
|
Direct |
4,667
+5.19%
|
$443,365
$95.11 P/Share
|
|
Oct 01
2020
|
Jeffrey D. Alter EVP, IngenioRx & Anthem Health |
BUY
Grant, award, or other acquisition
|
Direct |
2,746
+50.0%
|
-
|
|
Oct 31
2018
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Open market or private sale
|
Direct |
1,000
-4.44%
|
$270,000
$270.0 P/Share
|